51672 4029 01 B9265cf2
Warfarin Sodium Tablet
Product Images NDC 55154-4696
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Warfarin Sodium (NDC 55154-4696). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 01
This is a package of highly potent anticoagulant Warfarin Sodium 2.5 mg tablets, USP crystal with 10 tablets in the package. It contains a warning that this unit dose package is not child-resistant intended for institutional use only. If dispensed for outpatient use, a child-resistant container should be used. The drug must be kept out of reach of children. It also states that serious bleeding results from overdosage and should not be dispensed before reading directions and warnings in product information. The pharmacist is required to dispense with medication guide to each patient. The package should not be used if the blister is torn or broken. It provides information about the drug product, including the manufacturer and the distributor. The storage requirement is 20° to 25° C (68" to 77° F), with excursions permitted between 15" to 30° C (59" o 86" F) [see USP, Fantrolled Room Temperature]. It should be protected from light.*
Chemical Structure (Warfarin 01)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
